按美国心脏协会和美国心脏病学会标准诊断的慢性高血压与妊娠期高血压疾病风险增加相关
回顾性队列研究纳入3354例单胎妊娠孕妇,按美国心脏协会和美国心脏病学会标准诊断1期慢性高血压者占18%(629例)。该组妊娠期高血压(35.4% vs 20%,P<.001)和子痫前期(22.3% vs 10%,P<.001)发生率均高于不符合该标准者,校正混杂后风险比分别约为1.49和1.98。
要点
- 按AHA/ACC标准诊断1期慢性高血压者占18%(629/3354)。
- 该组妊娠期高血压发生率为35.4%,高于对照组的20%(P<.001)。
- 该组子痫前期发生率为22.3%,高于对照组的10%(P<.001)。
核心结论
- 数据提示符合美国心脏协会和美国心脏病学会1期慢性高血压标准的孕妇发生妊娠期高血压和子痫前期的风险增加。
- 未来研究需考虑妊娠期慢性高血压诊断是否应遵循美国心脏协会和美国心脏病学会标准,以及该标准诊断的1期慢性高血压者是否需要采用与美国妇产科医师学会标准诊断者相同的预防措施和干预。
研究设计与样本
- 回顾性队列研究,利用一家多元化、大型城市安全网医院的临床数据库。
- 纳入年龄18至40岁、单胎妊娠且孕早期接受产前保健者,共3354例。
- 按孕早期收缩压≥130 mm Hg或舒张压≥80 mm Hg定义符合美国心脏协会和美国心脏病学会1期慢性高血压标准,不符合者收缩压<130 mm Hg且舒张压<90 mm Hg。
- 未纳入按美国妇产科医师学会标准诊断的慢性高血压者(妊娠<20周时收缩压≥140 mm Hg或舒张压≥90 mm Hg),故符合美国心脏协会和美国心脏病学会标准者仅为收缩压130至139 mm Hg和舒张压80至89 mm Hg者。
主要发现
- 3354例中18%(629例)按美国心脏协会和美国心脏病学会标准诊断为1期慢性高血压。
- 该组妊娠期高血压发生率为35.4%,不符合该标准组为20%(P<.001)。
- 该组子痫前期发生率为22.3%,不符合该标准组为10%(P<.001)。
- 校正母亲年龄、种族、孕早期体重指数、孕前糖尿病和物质使用后,该组妊娠期高血压的校正风险比为1.49±0.10(P<.001)。
- 校正后该组子痫前期的校正风险比为1.98±0.19(P<.001)。
关键数值与推荐
- 美国妇产科医师学会标准:妊娠<20周时收缩压≥140 mm Hg或舒张压≥90 mm Hg诊断慢性高血压。
- 美国心脏协会和美国心脏病学会标准:收缩压≥130 mm Hg或舒张压≥80 mm Hg诊断慢性高血压。
- 妊娠期高血压和子痫前期诊断基于美国妇产科医师学会既定标准,子痫前期包括伴和不伴严重特征者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: ACOG uses a systolic blood pressure (SBP) ≥140 or diastolic blood pressure (DBP) ≥90 documented at <20 weeks of gestation to define chronic hypertension. In the nonpregnant state, the American Heart Association (AHA) and the American College of Cardiology (ACC) define chronic hypertension using lower diagnostic thresholds of SBP ≥130 or DBP ≥80. It remains unclear whether using more conservative guidelines in pregnancy improves identification of those at risk for gestational hypertension (GHTN) or preeclampsia (PRE). OBJECTIVE: We sought to investigate whether subjects with chronic hypertension based on the American Heart Association and American College of Cardiology criteria had an increased risk for gestational hypertension and preeclampsia than those without chronic hypertension. STUDY DESIGN: We conducted a retrospective cohort study utilizing a clinical database at a diverse, large urban, safety-net hospital. Subjects aged 18 to 40 years with singleton gestations and first trimester prenatal care were included. We defined subjects that met the criteria for stage 1 chronic hypertension based on first trimester systolic blood pressure and diastolic blood pressure cutoffs satisfying the American Heart Association and American College of Cardiology criteria (systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg). Those who did not meet these criteria had a systolic blood pressure <130 mm Hg and a diastolic blood pressure <90 mm Hg. We did not include those with chronic hypertension based on the American College of Obstetricians and Gynecologists criteria in this cohort (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg at <20 weeks); therefore, those who met the American Heart Association and American College of Cardiology criteria solely consisted of subjects with systolic blood pressure of 130 to 139 mm Hg and diastolic blood pressure of 80 of 89 mm Hg. By doing this, we were able to specifically investigate the increased risk for this specific population, which remains unclear. Diagnoses of gestational hypertension and preeclampsia were based on the established American College of Obstetricians and Gynecologists criteria. Preeclampsia included those with and without severe features. Tests for normality were performed. Student t-tests or rank sum tests were performed as appropriate for continuous variables; chi-square or Fisher's exact tests were performed for categorical variables. Generalized linear models were performed to calculate risk ratios while controlling for appropriate confounders. RESULTS: Of N=3354 subjects, 18% (n=629) were diagnosed with stage 1 chronic hypertension based on American Heart Association and American College of Cardiology criteria. Those with American Heart Association and American College of Cardiology stage 1 chronic hypertension had increased rates of gestational hypertension (35.4% vs 20%; P<.001) and preeclampsia (22.3% vs 10%; P<.001) than those without Stage 1 chronic hypertension based on these criteria. When controlling for maternal age, race, first trimester body mass index, pregestational diabetes, and substance use, those with the American Heart Association and American College of Cardiology stage 1 chronic hypertension had an almost 1.5-fold higher adjusted risk ratio of experiencing gestational hypertension (adjusted risk ratio, 1.49±0.10; P<.001) and almost 2-fold increased adjusted risk ratio of experiencing preeclampsia (adjusted risk ratio, 1.98±0.19; P<.001). CONCLUSION: Our data suggest an increased risk for developing gestational hypertension and preeclampsia for subjects satisfying the American Heart Association and American College of Cardiology cutoff for stage 1 chronic hypertension. Future studies need to consider whether diagnosis of chronic hypertension in pregnancy should conform with American Heart Association and American College of Cardiology criteria, and if those with stage 1 chronic hypertension based on American Heart Association and American College of Cardiology criteria require the same preventative measures and interventions utilized by those diagnosed by American College of Obstetricians and Gynecologists criteria.
引用
- Advani R, Chandrasekaran S. Chronic hypertension diagnosed by the American Heart Association and American College of Cardiology criteria is associated with increased risk of developing hypertensive disorders of pregnancy. Am J Obstet Gynecol MFM. 2023. PMID: 38145820. doi:10.1016/j.ajogmf.2023.101269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。